Garner, Will
https://orcid.org/0000-0003-0738-8696
Mayo Clinic
Mirum Pharmaceuticals, Inc., Foster City, Vereinigte Staaten
Citations 1
Volixibat zur Behandlung des cholestatischen Pruritus bei primär biliärer Cholangitis: Zwischenergebnisse der adaptiven, randomisierten, placebokontrollierten Phase-IIb-Studie (VANTAGE)
Trebicka, J, Shiffman, Mitchell L. , Weinstein, D, Ankoma‐Sey, Victor, Assy, N., Chiang, D Ting-Wei , Freedland, Curtis, Sanchez, A, Cai, Qiang , Samant, Hrishikesh , Roenn, Natasha M. Von, Kemmer, Nyingi , Kothadia, Jiten P. , Patel, Chirag, Venkatachalapathy, Suresh Vasan , Zigmond, Ehud , Zuckerman, Eli, Firipi-Morell, R, Wissniowski, T, Borg, Brian B. , Elgouhari, Hesham M., Habersetzer, François, McCorry, Roger, Neff, Guy , Smith, Connie Jo, Viganò, R., Brol, MJ, Chung, Youn Kyung , Krishnaswami, Jayshree, Garner, Will , Quan, Judy, Vig, Pamela , Trebicka, Jonel , Kowdley, Kris V. , Weinstein, Debra, Brunetto, Maurizia Rossana , Forman, L, Bonder, Alan , Eaton, J, Thapar, Manish , Agrawal, Namita , Boike, Justin , Lleò, Ana , Louvet, Alexandre , Smith, C, Tran, Albert , Uschner, Frank Erhard , Brol, Maximilian Joseph , Chung, Y, Ergenç, İlkay , Nunes, Tiago , Gugelmann, Hallam M. , Krishnaswami, Jayshree, Quan, J, Heneghan, Michael A.
Zeitschrift für Gastroenterologie | September 4, 2025 | Volume: 63 | Issue: No issue available | Pages: No page available
